Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Dr Rebecca Clark

Research Fellow

United Kingdom

Jump to: Affiliations Research Publications
I have a PhD in Infectious Disease Epidemiology from LSHTM, an MSc in Epidemiology from the University of Alberta and a BSc (Honours) in Biology and Mathematics from McMaster University. I am currently a Research Fellow in the Department of Infectious Disease Epidemiology & Dynamics at LSHTM. My research is focussed on using mathematical modelling to evaluate the health and economic impacts of interventions to reduce the burden of tuberculosis, primarily of new vaccines.

Affiliations
Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Research
Research Area
Epidemiology
Mathematical modelling
Vaccines
Disease and Health Conditions
Tuberculosis
Country
India

Selected Publications
Estimating the potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study
CLARK, RA; Portnoy, A; Weerasuriya, CK; SUMNER, T; Bakker, R; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;
2024
The Lancet regional health - Southeast Asia
Bridging the gap: evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults: a workshop report
CLARK, RA; Young, C; Palmer, S; Auma, E; Malhotra, S; Limaye, R; Giersing, B; Schrager, L; Voss, G; Tiemersma, E; Frick, M; Edoka, I; Dagnew, AF; Nkhoma, T; Pelzer, PT; WHITE, RG;
2024
Frontiers in Tuberculosis
Estimating the Potential Public Health Value of BCG Revaccination.
CLARK, RA; SUMNER, T; Weerasuriya, CK; Bakker, R; Scriba, TJ; WHITE, RG;
2024
The Journal of infectious diseases
New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01E and BCG-revaccination.
CLARK, RA; Weerasuriya, CK; Portnoy, A; Mukandavire, C; Quaife, M; Bakker, R; Scarponi, D; Harris, RC; Rade, K; Mattoo, SK; Tumu, D; Menzies, NA; WHITE, RG;
2023
BMC medicine
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.
CLARK, RA; Mukandavire, C; Portnoy, A; WEERASURIYA, CK; Deol, A; SCARPONI, D; Iskauskas, A; Bakker, R; Quaife, M; Malhotra, S; Gebreselassie, N; Zignol, M; Hutubessy, RC W; Giersing, B; JIT, M; Harris, RC; Menzies, NA; WHITE, RG;
2023
The Lancet. Global health
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
Portnoy, A; CLARK, RA; Quaife, M; WEERASURIYA, CK; Mukandavire, C; Bakker, R; Deol, AK; Malhotra, S; Gebreselassie, N; Zignol, M; Sim, SY; Hutubessy, RC W; Baena, IG; Nishikiori, N; JIT, M; WHITE, RG; Menzies, NA;
2023
PLOS Medicine
New tuberculosis vaccines: advances in clinical development and modelling.
WEERASURIYA, CK; CLARK, RA; WHITE, RG; Harris, RC;
2020
Journal of internal medicine
The potential impact of new TB vaccines on the burden of TB in people living with HIV in South Africa.
SUMNER, T; CLARK, RA; PRYS-JONES, TO; Bakker, R; Churchyard, G; WHITE, RG;
2024
AIDS
Estimating the Potential Public Health Value of BCG Revaccination.
CLARK, RA; SUMNER, T; Weerasuriya, CK; Bakker, R; Scriba, TJ; WHITE, RG;
2024
The Journal of infectious diseases
The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.
WHITE, RG; Menzies, NA; Portnoy, A; CLARK, RA; Toscano, CM; Weller, C; Tufet Bayona, M; Silal, SP; Karron, RA; Lee, J-S; Excler, J-L; Lauer, JA; Giersing, B; Lambach, P; Hutubessy, R; JIT, M;
2024
Vaccines
See more information
Rebecca Clark

Contact

United Kingdom

Discover More

Related links

LinkedIn
Twitter
ResearchGate